Dr Lal PathLabs Q3 Results 2026: Well-known lab diagnostic company Dr Lal PathLabs has approved its financial results for Q3 2026. The board has declared a third interim dividend of Rs 3.5 for investors along with the quarterly results. Additionally, the Board also approved allotment of equity shares under the Employee Stock Option Plan.
Dr Lal PathLabs Dividend, Q3 Results 2026: Pharma company announced quarterly results, investors got good news of dividend – Market
